COVID-19 Vaccine Trial Data Shows a Negative Benefit to Harm Ratio in New Peer-Reviewed Paper
An important new paper was published in volume 40, issue 35 of the peer-reviewed Vaccine journal. Both the Moderna and the Pfizer COVID-19 vaccine trial data appeared to have a negative benefit/harm ratio. Peter Doshi.
“Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults.”
